Trademark Search in Canada

NaNotics

View On IC.GC.CA

REGISTERED

on 16 Nov 2022

Last Applicant/ Owned by

NaNotics, LLC

531 Midvale Way Mill Valley, CA 94941

Serial Number

1874357 filed on 21^st Dec 2017

Registration Number

TMA1089073 registered on 16^th Nov 2022

Registration expiry Date

16^th Nov 2032

Correspondent Address

CPST INTELLECTUAL PROPERTY INC.

130 Queens Quay EastEast Tower, Suite 809Toronto,

ONTARIO

M5A0P6

NaNotics

Trademark usage description

pharmaceutical preparations for the treatment of substance addiction, diseases of ageing, namely loss of physical and mental function associated with Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of substance addiction, diseases of ageing, namely loss of physical and mental function associated with ageing, age-related cognitive decline, dementia, musculoskeletal disease, senescence of bodily tissues, allergic rhinitis, Alzheimer's, ankylosing spondylitis, asthma, atherosclerosis, cancer, chronic fatigue syndrome (CVS), Crohn's disease, colitis / ulcerative, cardiovascular disease (CVD), dementia, depression, diabetes / T2, eczema / atopic (AE), Epstein-Barr virus (EBV), fungal Infections, Graft versus host disease (GVHD), Hodgkin's disease, idiopathic pulmonary fibrosis (IPF), bacterial infection, viral infection, leukemia, lupus, lymphoma, macular degeneration, malaria, Methicillin-resistant Staphylococcus aureus (MRSA), multiple sclerosis, myasthenia gravis, obesity, pain, parasites, pre-eclampsia, psoriasis, post-traumatic stress disorder (PTSD), renal disease, rheumatoid arthritis, sepsis, Sjogren's syndrome, transplant rejection, autoimmune diseases, Juvenile Idiopathic Arthritis, Cytokine Release Syndrome and osteoporosis; drug delivery agents in the form of nano-capsules and micro-capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals all of the foregoing excluding radioenhancers for use with radiotherapy

Classification kind code

Class [010]
Medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove aberrant cell signals circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove aberrant cell signals circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove aberrant cell signal inhibitors circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove aberrant cell signal inhibitors circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove metabolites circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove metabolites circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove antibodies circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove antibodies circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove enzymes circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove enzymes circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove toxins circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove toxins circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove vesicles circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove vesicles circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove exosomes circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove exosomes circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove drugs circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove drugs circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove allergens circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove allergens circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove proteins circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove proteins circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove peptides circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove peptides circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove nucleic acids circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove nucleic acids circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove lipids circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove lipids circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove carbohydrates circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove carbohydrates circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable micro-scale devices containing capture agents that bind to and remove sugars circulating in blood within the body to treat diseases; medical apparatus and units for dosage, measuring and monitoring, and for introducing pharmaceutical preparations into the body of a human or animal, namely, injectable nano-scale devices containing capture agents that bind to and remove sugars circulating in blood within the body to treat diseases all of the foregoing excluding radioenhancers for use with radiotherapy

Classification kind code

Mark Details

Serial Number

1874357

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 7^th Aug 2020	Approved
Submitted for opposition 27 on 7^th Aug 2020	Approval Notice Sent
Submitted for opposition 15 on 29^th Apr 2020	Correspondence Created
Submitted for opposition 48 on 13^th Mar 2020	Agent Changed
Submitted for opposition 15 on 11^th Sept 2019	Correspondence Created
Submitted for opposition 22 on 6^th Feb 2019	Search Recorded
Submitted for opposition 20 on 6^th Feb 2019	Examiner's First Report
Submitted for opposition 31 on 27^th Dec 2017	Formalized
Submitted for opposition 1 on 22^nd Dec 2017	Created
Submitted for opposition 30 on 21^st Dec 2017	Filed